Kanda Ramasamy

Kanda Ramasamy has extensive experience in the pharmaceutical industry, specializing in conjugation and oligonucleotide chemistry. Currently serving as Sr. Director at DTx Pharma, Kanda is known for technology development, novel motif design, and application of conjugation chemistry for delivering siRNA to different tissues. With previous roles at companies like Cepheid, Thermo Fisher Scientific, Valeant Pharmaceuticals, and Isis Pharmaceuticals, Kanda has a strong background in proposal development, process development, technology transfer, manufacturing, and analytical methods for oligonucleotides.